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INTRODUCXION
DNA is methylated at the polynucleotide level, which occurs at the 5-position of certain cytosincs found predominately in the dinucleotide CpG ( I ) (Fig. I) . In mammalian DNA, the content of 5-methylcytosine is 2-7% of the cytosincs being methylated, and different areas of the genome are methylated, depending upon the species. The qualitative aspect of DNA methylation and many recent studies on the methylation of specific genes has given support to the hypothesis that DNA methylation is a part of the mechanism of gene expression. Data to support this hypothesis are summarized in several recent reviews (5, 14, 18, 24, 25) . Although not conclusive at this time, it does appear that in cells with 5-methylcytosine in their DNA, the 5-methylcytosine is a part ofthe mechanism ofgene expression. Therefore, the regulation of DNA methylation via DNA methyltransferase and S-adenosylmethionine (AdoMet) becomes very important.
DNA methyltransferase has been purified from several sources ( I , 22, 26, [30] [31] [32] . The purified en-* Presented at the Third Sardinian International Symposium, October 6-9, 1985 in Cagliari, Italy. zyme exhibits two types of activity, maintenance and de tiovo methylation. The maintenance activity methylatcs the DNA in a semi-conservative fashion, thereby maintaining the normal methylation pattern of the cell. On the other hand, the de nova activity allows for the methylation of new sites, thus altering the normal methylation pattern (Fig. 2 ). It has been proposed that changes in the DNA methylation pattern is a part of the mechanism for differentiation and carcinogenesis. Borek (3) was among the first to suggest that an alteration in the DNA methylation pattern might be involved in the initiation of carcinogenesis. This hypothesis is supported by recent evidence that various carcinogens induce a hypomethylation state in newly synthesized DNA (25) . Therefore, what is the mechanism for carcinogen induced hypomethylated DNA? We have been studying three possible mechanisms for carcinogen alterations of DNA methylation ( Fig. 3) : 1) Since animals on a carcinogenic diet have reduced tissue levels of AdoMet (4, 19, 22, 23, 29) , a low level of the substrate for DNA methyltransferase could alter the methylation pattern. 2) Some carcinogens react directly with DNA, making it less effective as a substrate for the DNA methylase 9,34), thus DNA-carcinogen adducts could alter the methylation pattern. 3) Other carcinogens react directly with the DNA methyltransferase (7, 10-12) to inhibit the enzyme, resulting in the hypomcthylation of DNA. In reality, for any given carcinogen a combination of the above mentioned mechanisms may be occurring in the carcinogen-fed animal.
METHODS

Animals used in these experiments were male
Sprague Dawley rats weighing 100 to 125 g; they were obtained from Charles River Breeding Laboratories, Inc., Wilmington, MA. Two-thirds partial hepatectomy was performed as described by Higgins and Anderson (17) . Penthrane was used as an inhalation anesthetic and all animals received a 10% solution of dextrose for drinking water for 24 hr.
DNA Methylase Preparation. Purified nuclei were isolated from the liver of rats as previously described (7,8). DNA methylase activity was extracted from nuclei as first described by Simon (3) and modified by Lapeyre et al (21) . The salt extract was further purified by chromatography on DEAE-Sephacel as described by Bcstor and Ingram (1). Whole nuclei, the crude salt extract, and the peak ofactivity from the DEAE-Sephacel column were used as the source of DNA methylase in the different experiments described under results.
Metliylation Assay. The DNA methylase was incubated with S-adeno~yl-[methyl-~H]-methionine (2.0 p~, 5mCilmrnol) in a total volume of 200 pl
M a i n t e n a n c e
--Illustration of the maintenance and de iiovo activities of DNA methylase. containing 10 mM EDTA and 50 mM Tris-HC1 at pH 7.4. Micrococciis lysodeikticiis DNA or hypomethylated DNA prepared from ethionine-treated rats (7) was used as a substrate and the mixture was incubated for 1 hr at 37°C in a shaking water bath. The reaction was stopped by adding 0.1 ml of 4 M NaCl and chilling in ice. RNA and protein were removed as previously described ( I 7) and the DNA hydrolyzed in 1 ml of 0.6 N perchloric acid for 15 minutes. Aliquots were counted for radioactivity in 10 ml of scintillation fluid with a Packard liquid scintillation counter.
5-Methylcytosine has bcen identified as the only product of this reaction by enzymatic and acid hydrolysis of the purified DNA with column and paper chromatography as previously described (7).
Alkylaled DNA. Methyl-deficient DNA was alkylated in vitro with N-methyl-N-nitrosourea (MNU). MNU was dissolved in ethanol at 10 mg/ ml. Aliquots of this solution were removed and placed in small test tubes. The ethanol was removed by a stream of filtered air. A buffer of 10 m M Tris-1 mM EDTA (pH 7.5) (0.5 ml) was added to dissolve the MNU. Immediately, 1 mg of DNA in water (1.5 ml) was added and the solution incubated at 37°C for 1 hr. The solution was then made 1 M NaCl by adding 4 M NaCl. Two ml of isopropanol were layered on top and the DNA precipitated by gentle swirling. The DNA was again dissolved in 1 ml of water and the concentration determined by the diphenylamine assay (6). At this point, the DNA was labeled MNU-alkylated methyl-deficient DNA and used as a substrate in the methylation assay. Ethionine (300 mag) was give PO 17 hr after partial hepatectomy. Six hr later 400 pCi of [me~hyl-~II]-methionine was given ip, and 2 hr later the DNA was purified, enzymatically hydrolyzcd, and chromatographed to determine specific activity.
RESULTS
Ethionine, a liver carcinogen for the rat, reacts with ATP to form S-adenosylethionine (AdoEth), which accumulates in the hepatic tissue (7, 15). We have previously reported that AdoEth competitively inhibits the enzymatic methylation of DNA (7). Since AdoEth accumulates in the liver of rats and inhibits DNA methylase, experiments were done to show the inhibition of DNA methylation in vivo. Rats were given ethionine (300 mg/kg) 17 hr after partial hepatectomy to allow DNA synthesis to continue and at the same time to maintain high liver concentrations of AdoEth (1.5 to 2.0 pmovg). The data show a 98% inhibition of incorporation of methyl group of [methyl-3H]-methionine into 5-methyl-deoxycytidine (Table I) . When correcting for DNA synthesis (dSMC/dT), a 97% inhibition was still observed. These data strongly suggest that ethionine inhibits the methylation of newly synthesized DNA in regenerating rat liver. To confirm this hypothesis, nuclei were isolated from control and ethionine-treated rats and assayed in vitro for DNA methylation (Table 11) . DNA from ethionine-treated rats received methyl groups about 8 times greater than control. These data suggest that AdoEth, formed in vivo from ethionine, competitively inhibits the methylation of DNA in vivo by AdoMet, resulting in the production of hypomethylated DNA.
Direct acting alkylating carcinogens could react directly with guanines in the CpG sites of the DNA or with the DNA methylase protein. When added directly to the in vitro assay, N-methyl-"-nitro-N-nitrosoguanidine (MNNG) inhibited the methylation of DNA (Table 111 ), whereas no effect was observed with MNU. Dithiothreitol at 50 p~ completely protects the DNA methylase from MNNG (3.2 pg/assay) inhibition, suggesting the presence of -SH groups on the enzyme. Iodoacetamide (100 p~) inhibited the activity of DNA methylase by 45%, further suggesting the presence of -SH groups on DNA methylase, that are necessary for a functional enzyme.
Since MNU did not inhibit the enzyme directly in the above experiments, studies were done to determine if DNA alkylated with the carcinogen MNU, which could serve as a substrate for DNA methylase. Alkylated, hypomethylated DNA (from ethioninetreated rats) (7, 9) was used as a substrate in an in vifro assay with homologous rat-liver DNA methylase. The data show that as the percent ofguanines alkylated increases, methylation decreases (Table   IV) , indicating that the presence of 7-methylguanine and/or 06-methylguanine at the CpG sites inhibits the methylation of cytosine by DNA methylase.
Selenium has been reported to have carcinogenic and anti-carcinogenic activity (28) . It also induces the differentiation of Friend erythroleukemic cells (1 3) and was found to bc a very good inhibitor of DNA methylase. At 10 p~, sodium selenite inhibited the methylase reaction by 50%. A substrate curve for AdoMet in the absence and presence of 5 and Table 111 ). 50 PM selcnitc demonstrated a noncompetitive type of inhibition by selenite, with a Ki of 6.7 PM (data not shown). Dithiothreitol has no effect on selenite inhibition, suggesting that -SH groups are not a part of the mechanism of selenite inhibition. The data
in Table V suggest that selenite is affecting the DNA methylase iti viro. At an intravenous dose of 3 mg/ kg, the activity was inhibited by 55-60%. 5-Azacytidine is incorporated into DNA and irreversibly binds the enzyme DNA methylase (20, 27) . It is also suspected to be a weak carcinogen (1 6), thus supporting the hypothesis that DNA methylation may play a role in the initiation of carcinogenesis. We have attempted to alter the methylase activity in regenerating rat liver with 5-azacytidinc. DNA methylase activity is increased 2 to 3 fold in 2-day regenerating rat liver (Fig. 4) . A single dose of 5-azacytidine (10 mg/kg) inhibited the methylase activity in 24-hr regenerating liver by 70%. However, the inhibition at 24 hr is a transient effect and at 72 hr the enzyme activity is 3 times the normal level. In both the control and the 5-azacytidinetreated animals, the peak of DNA methylase activity follows the peak of DNA synthesis by 24 hr. In both the situations the enzyme activity returns to normal levels by day 5.
DISCUSSION
Several carcinogens have been found to inhibit the enzymatic methylation of DNA (2, 7, (9) (10) (11) (12) 34) . The data support the hypothesis that altering the normal DNA methylation pattern in cells is a part of the initiating mechanisms of carcinogenesis. Chemical carcinogens may alter DNA methylation a Sodium selenite was given iv to 125 g rats (3 ratdgroup) and the animals sacrificed 6 hr later. DNA methylase was prepared and assaycd as described in METHODS.
by: 1) lowering the tissue levels ofAdoMet, the substrate for DNA methylase; 2) directly inhibiting the enzyme, DNA methylase; or 3) reacting directly with the DNA substrate, rendering it less effective as a substrate. More than one of these mechanisms may be occumng with any given carcinogen. Animals on a carcinogenic diet have reduced levels of AdoMet (13) (14) (15) (16) , which may be a contributing factor to altering DNA methylation. In fact, rats fed a noncarcinogenic choline-devoid diet have a 50% reduced level of AdoMet (Cox, unpublished observations) and the addition of 0.05% ethionine to the diet induces liver cancer (1 5). Ethionine given in acute or chronic doses reacts with ATP to form AdoEth, which accumulates in the hepatic tissues. AdoEth competitively inhibits DNA methylase (7) and our results clearly show that in rats receiving an acute dose of ethionine, the AdoEth levels are suficient to inhibit DNA methylation. Even though AdoEth itself has been shown to be carcinogenic (33), the question remains, is AdoEth necessary for ethionine carcinogenesis? It does appear that ethionine alters DNA methylation via AdoEth's inhibition of the methylase enzyme.
MNNG and MNU, direct acting alkylating carcinogens, both inhibit the methylation of DNA in an in vitro assay, but by different mechanisms. MNNG was shown to react with -SH groups on the DNA methylase (10, 12), thus directly inactivating the enzyme. It remains to be determined ifthis effect occurs iri viro. MNU had no effect on the ill vitro assay when added directly at the concentrations used. However, when DNA was alkylated with MNU and then used as a substrate for the assay, the enzymatic methylation of DNA was inhibited. This has been demonstrated also for several carcinogens iri vitro and in cultured cells (4, 19) .
The observation that selenium inhibits DNA methylase activity is novel, interesting, and probably useful in further studies with DNA methylase. We first thought that selenite might bind to the -SH groups of the DNA methylase. However, we were unable to overcome the inhibition by adding dithiothreitol to the assay, suggesting that -SH groups
